{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:34Z","timestamp":1793042794974,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010600","name":"Tampere University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajog.2026.02.038","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:39:52Z","timestamp":1772005192000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genotype and age shape the risk of persistent high-risk human papillomavirus infections"],"prefix":"10.1016","volume":"235","author":[{"given":"Eero","family":"Numminen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarno","family":"Leino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Karhula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Fonagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Seiskari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Paloniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Kholov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Kares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-363X","authenticated-orcid":false,"given":"Karolina","family":"Louvanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.02.038_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2026.02.038_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2026.02.038_bib4","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2026.02.038_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ajog.2026.02.038_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.32291","article-title":"Bayesian analysis of baseline risk of CIN2 and \u2265CIN3 by HPV genotype in a European Referral Cohort","volume":"145","author":"Bonde","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23280","article-title":"HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT","volume":"23","author":"Gilham","year":"2019","journal-title":"Health Technol Assess Winch Engl"},{"key":"10.1016\/j.ajog.2026.02.038_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2026.02.038_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2019.05.026","article-title":"Association of age and viral factors with high-risk HPV persistence: a retrospective follow-up study","volume":"154","author":"Li","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2026.02.038_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.927131","article-title":"Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection","volume":"12","author":"Ntuli","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajog.2026.02.038_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.ajog.2026.02.038_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajog.2026.02.038_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/biology13020077","article-title":"The hallmarks of cervical cancer: molecular mechanisms induced by human papillomavirus","volume":"13","author":"Rosendo-Chalma","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.ajog.2026.02.038_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2026.02.038_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/147323001204000210","article-title":"Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia","volume":"40","author":"Kim","year":"2012","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ajog.2026.02.038_bib17","series-title":"Working group set up by the Finnish Medical Society Duodecim and the Finnish Colposcopy Association","article-title":"Current Care Guidelines","year":"2023"},{"key":"10.1016\/j.ajog.2026.02.038_bib18","first-page":"548","article-title":"Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia","volume":"34","author":"Du","year":"2013","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ajog.2026.02.038_bib19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/ijc.24794","article-title":"Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia","volume":"126","author":"Kim","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.30623","article-title":"Patterns of persistent HPV infection after treatment for Cervical Intraepithelial Neoplasia (CIN): a systematic review","volume":"141","author":"Hoffman","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1055-9965.EPI-06-0710","article-title":"Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3","volume":"16","author":"Kreimer","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ajog.2026.02.038_bib22","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2026.02.038_bib23","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2026.02.038_bib24","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.31883","article-title":"Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types","volume":"144","author":"Sand","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/aogs.14021","article-title":"Primary HPV screening for cervical cancer: results after two screening rounds in a regional screening program in Finland","volume":"100","author":"Veijalainen","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2026.02.038_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.ajog.2026.02.038_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.29719","article-title":"Factors associated with type-specific persistence of high-risk human papillomavirus infection: a population-based study","volume":"138","author":"Stensen","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","article-title":"Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis","volume":"133","author":"Rositch","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ijc.70123","article-title":"Long-term human papillomavirus genotype-specific risk of cervical high-grade intraepithelial lesion and cancer-By age group and triage cytology","volume":"158","author":"Vahteristo","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib30","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.31390","article-title":"Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears","volume":"143","author":"Vintermyr","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ijc.31326","article-title":"Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more","volume":"143","author":"Del Mistro","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/jnci\/djaf055","article-title":"HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology","volume":"117","author":"Adcock","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2026.02.038_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-World effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2026.02.038_bib35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ijc.35044","article-title":"Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions","volume":"155","author":"Louvanto","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib36","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.chom.2023.10.001","article-title":"Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts","volume":"31","author":"Pimenoff","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ajog.2026.02.038_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7406a4","article-title":"Trends in cervical precancers identified through population-based surveillance - human papillomavirus vaccine impact monitoring project, five sites, United States, 2008-2022","volume":"74","author":"Gargano","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2026.02.038_bib38","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","article-title":"Human papillomavirus vaccination","volume":"388","author":"Markowitz","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2026.02.038_bib39","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2026.02.038_bib40","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JCM.00783-10","article-title":"Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study","volume":"48","author":"Louvanto","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajog.2026.02.038_bib41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ijc.22015","article-title":"Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus","volume":"119","author":"Koshiol","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.34128","article-title":"Different human papillomavirus types share early natural history transitions in immunocompetent women","volume":"151","author":"Adebamowo","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1471-0528.16460","article-title":"Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English cervical screening programme","volume":"128","author":"Bennett","year":"2021","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2026.02.038_bib44","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/ijc.32540","article-title":"Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: the Psychological Impact of Primary Screening (PIPS) study","volume":"146","author":"McBride","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib45","first-page":"255","article-title":"Patterns of anxiety and distress over 12 months following participation in HPV primary screening","volume":"98","author":"Marlow","year":"2022","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ajog.2026.02.038_bib46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/pon.5897","article-title":"Psychosocial impact of testing human papillomavirus positive in Australia\u2019s human papillomavirus-based cervical screening program: a cross-sectional survey","volume":"31","author":"Chadwick","year":"2022","journal-title":"Psychooncology"},{"key":"10.1016\/j.ajog.2026.02.038_bib47","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.7150\/jca.57993","article-title":"Genotype-specific distribution and change of high-risk human papillomavirus infection and the association with cervical progression risk in women with normal pathology and abnormal cytology in a population-based cohort study in China","volume":"12","author":"Jia","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.ajog.2026.02.038_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70193","article-title":"A 10-year retrospective analysis on HPV genotype switching in a tertiary center in China: infection characterization and clinical outcome","volume":"97","author":"Bi","year":"2025","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajog.2026.02.038_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000573","article-title":"Human papillomavirus same genotype persistence and risk: a systematic review","volume":"25","author":"Bonde","year":"2021","journal-title":"J Low Genit Tract Dis"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:53:13Z","timestamp":1781628793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937826001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0002937826001213"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.02.038","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype and age shape the risk of persistent high-risk human papillomavirus infections","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}